Hims & Hers Health to introduce generic Liraglutide in 2025 amid growing demand for weight-loss…
The move taps into surging demand for appetite-suppressing GLP-1 agonists, set against ongoing shortages of newer weight-loss…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Liraglutide
Biocon partners with Handok to commercialise Liraglutide in South Korea
Biocon to develop and supply Liraglutide; Handok to handle regulatory approval and commercialisation in South Korea.
Glenmark launches biosimilar of anti-diabetic drug, Liraglutide, in India
It is priced at around Rs 100 for a standard dose of 1.2 mg (per day)
Biocon signs commercialisation pact with Juno Pharma in Canada for Liraglutide
Liraglutide is a drug-device combination for the treatment and management of Type 2 diabetes and obesity